Edition:
United Kingdom

Cymabay Therapeutics Inc (CBAY.OQ)

CBAY.OQ on NASDAQ Stock Exchange Global Select Market

8.73USD
11 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$8.73
Open
$8.91
Day's High
$8.92
Day's Low
$8.62
Volume
82,903
Avg. Vol
166,314
52-wk High
$15.59
52-wk Low
$7.39

Chart for

About

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. The Company's product candidates include Arhalofenate, MBX-8025 and MBX-2982. Arhalofenate is used to treat gout. MBX-8025 is a... (more)

Overall

Beta: 2.08
Market Cap(Mil.): $358.81
Shares Outstanding(Mil.): 43.76
Dividend: --
Yield (%): --

Financials

  CBAY.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -1.06 -- --
ROI: -182.71 0.29 15.02
ROE: -308.78 0.94 16.60

Earnings vs. Estimates